XML 81 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION
 9 Months Ended
Apr. 30, 2013
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
The Company’s reportable segments, which are also its operating segments, consist of the Company’s Life Sciences and Industrial businesses.
The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes, for the three and nine months ended April 30, 2013 and April 30, 2012.
 
Three Months Ended
 
Nine Months Ended
 
Apr 30, 2013
 
Apr 30, 2012
 
Apr 30, 2013
 
Apr 30, 2012
SALES:
 
 
 
 
 
 
 
Life Sciences
$
326,097

 
$
317,969

 
$
955,230

 
$
918,954

Industrial
315,093

 
340,007

 
976,015

 
1,030,331

Total
$
641,190

 
$
657,976

 
$
1,931,245

 
$
1,949,285

SEGMENT PROFIT:
 
 
 
 
 
 
 
Life Sciences
$
81,195

 
$
75,386

 
$
233,514

 
$
233,191

Industrial
45,853

 
39,431

 
146,723

 
131,195

Total segment profit
127,048

 
114,817

 
380,237

 
364,386

Corporate Services Group
15,172

 
16,397

 
47,263

 
49,776

Operating profit
111,876

 
98,420

 
332,974

 
314,610

ROTC
12,824

 
2,861

 
21,497

 
31,001

Interest expense, net
5,298

 
6,351

 
10,747

 
17,682

Earnings from continuing operations before income taxes
$
93,754

 
$
89,208

 
$
300,730

 
$
265,927